Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pallab Pradhan

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Frontiers in Immunology|March 26, 2021
Polymeric Pathogen-Like Particles-Based Combination Adjuvants Elicit Potent Mucosal T Cell Immunity to Influenza A VirusBrock Kingstad-Bakke, Randall Toy, Woojong Lee, et al.
Biomaterials|October 5, 2019
Modification of primary amines to higher order amines reduces in vivo hematological and immunotoxicity of cationic nanocarriers through TLR4 and complement pathwaysRandall Toy, Pallab Pradhan, Vijayeetha Ramesh, et al.
Biorxiv : the Preprint Server for Biology|February 8, 2022
Nanoparticle-delivered TLR4 and RIG-I agonists enhance immune response to SARS-CoV-2 subunit vaccineAlexandra Atalis, Mark C Keenum, Bhawana Pandey, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 7, 2020
TLR7 and RIG-I dual-adjuvant loaded nanoparticles drive broadened and synergistic responses in dendritic cells in vitro and generate unique cellular immune responses in influenza vaccinationRandall Toy, M Cole Keenum, Pallab Pradhan, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 16, 2022
Nanoparticle-delivered TLR4 and RIG-I agonists enhance immune response to SARS-CoV-2 subunit vaccineAlexandra Atalis, Mark C Keenum, Bhawana Pandey, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 10, 2019
Extended delivery of vaccines to the skin improves immune responsesJessica C Joyce, Hila E Sella, Heather Jost, et al.
Nano Letters|January 4, 2021
Bifunctional Janus Particles as Multivalent Synthetic Nanoparticle Antibodies (SNAbs) for Selective Depletion of Target CellsJiaying Liu, Randall Toy, Casey Vantucci, et al.
Mabs|November 6, 2023
Robust production of monovalent bispecific IgG antibodies through novel electrostatic steering mutations at the C<sub>H</sub>1-C<sub>λ</sub> interfaceJohn D Bagert, Vaheh Oganesyan, Chi-I Chiang, et al.
Mabs|August 29, 2024
IL-2-armored peptide-major histocompatibility class I bispecific antibodies redirect antiviral effector memory CD8+ T cells to induce potent anti-cancer cytotoxic activity with limited cytokine releaseJohn S Schardt, Even Walseng, Kim Le, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Frontiers in Immunology|March 26, 2021
Polymeric Pathogen-Like Particles-Based Combination Adjuvants Elicit Potent Mucosal T Cell Immunity to Influenza A VirusBrock Kingstad-Bakke, Randall Toy, Woojong Lee, et al.
Biomaterials|October 5, 2019
Modification of primary amines to higher order amines reduces in vivo hematological and immunotoxicity of cationic nanocarriers through TLR4 and complement pathwaysRandall Toy, Pallab Pradhan, Vijayeetha Ramesh, et al.
Biorxiv : the Preprint Server for Biology|February 8, 2022
Nanoparticle-delivered TLR4 and RIG-I agonists enhance immune response to SARS-CoV-2 subunit vaccineAlexandra Atalis, Mark C Keenum, Bhawana Pandey, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 7, 2020
TLR7 and RIG-I dual-adjuvant loaded nanoparticles drive broadened and synergistic responses in dendritic cells in vitro and generate unique cellular immune responses in influenza vaccinationRandall Toy, M Cole Keenum, Pallab Pradhan, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 16, 2022
Nanoparticle-delivered TLR4 and RIG-I agonists enhance immune response to SARS-CoV-2 subunit vaccineAlexandra Atalis, Mark C Keenum, Bhawana Pandey, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 10, 2019
Extended delivery of vaccines to the skin improves immune responsesJessica C Joyce, Hila E Sella, Heather Jost, et al.
Nano Letters|January 4, 2021
Bifunctional Janus Particles as Multivalent Synthetic Nanoparticle Antibodies (SNAbs) for Selective Depletion of Target CellsJiaying Liu, Randall Toy, Casey Vantucci, et al.
Mabs|November 6, 2023
Robust production of monovalent bispecific IgG antibodies through novel electrostatic steering mutations at the C<sub>H</sub>1-C<sub>λ</sub> interfaceJohn D Bagert, Vaheh Oganesyan, Chi-I Chiang, et al.
Mabs|August 29, 2024
IL-2-armored peptide-major histocompatibility class I bispecific antibodies redirect antiviral effector memory CD8+ T cells to induce potent anti-cancer cytotoxic activity with limited cytokine releaseJohn S Schardt, Even Walseng, Kim Le, et al.
Pageof 3